T he PR interval, accessible from the ECG, measures the duration of atrial and atrioventricular nodal conduction. Automated software routinely quantifies the median PR interval in clinical settings. As established by large-sized cohorts, PR interval increases progressively with age.
Body Composition (Health ABC) Study, a prospective, biracial cohort of older adults. We hypothesized that PR interval would be significantly associated with heart failure, AF, and all-cause mortality in a cohort of older adults after accounting for established clinical risk factors. We sought to identify racial differences in PR interval as an exposure, especially because blacks have been reported to have less incident AF than whites, 8 despite observed differences in PR duration.
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Methods
Study Cohort
Health ABC is a longitudinal cohort study examining the association of body composition with health outcomes. Participants were recruited from a random sampling of white Medicare beneficiaries in areas surrounding Pittsburgh, PA, and Memphis, TN, and all age-eligible blacks in the same zip codes. Enrollment criteria included age 70 to 79 years, white or black race, capacity to perform mobility-related activities of daily living, and absence of functional disability. 10 The initial examination included a standardized physical, anthropometric assessment, laboratory, motor, and cognitive assessments, body imaging, and medications. Health ABC's baseline examination (1997) (1998) consisted of 3075 participants (52% women and 42% black) who have been followed with telephone contacts at 6-month intervals and clinic examinations in years 1 to 6, 8, 10, and 11. The study completed its 14th year, 2010 to 2011.
The present analysis excluded participants with missing ECG data or PR intervals <80 ms (n=81); atrial or other supraventricular arrhythmias including AF, ventricular preexcitation (WolffParkinson-White), second-degree or higher heart block, or paced rhythm (n=136); absence of the examined covariates (n=133); and lacking outcome data (n=3). Participants with prevalent heart failure (n=64) were excluded from the analysis examining heart failure as an outcome. Participants with prevalent AF (n=126) or lacking Center for Medicare and Medicaid data (n=23) were excluded from analysis examining incident AF. The study protocols of Health ABC were approved by the Institutional Review Boards at the University of Pittsburgh and the University of Tennessee. All participants provided written informed consent.
Electrocardiography and PR Interval Measurement
Twelve-lead ECGs for the present investigation were collected at the baseline examination (Marquette Electronics MAC PC) by standardized protocol. ECG tracings were submitted to the St. Louis University Core ECG Laboratory (St. Louis, MO) for analysis, where ECG analysis was blinded to participant demographics. Two independent coders analyzed each ECG for standard intervals (heart rate, PR, QRS, and QT intervals) and amplitudes (R, S, and T waves and J and ST segments) as described elsewhere. 11 The PR interval was determined as beginning at the T-P junction at the start of the P wave to the initiation of the QRS segment. Measurements of the PR interval were made in lead II using a 7-power magnifying loupe on a grid with 0.1 mm calibration. The PR interval was determined as the average measure from 3 consecutive beats or 2 at slower heart rates (<50 beats per minute). Interreader discrepancies were resolved by direct comparison and adjudication by a supervisor. The St. Louis University Core ECG Laboratory has reported excellent reliability assessments. 11 Interreader reproducibility assessments for PR interval measurement found a coefficient of reliability of 0.997 and a Pearson correlation coefficient of 0.997. A paired t test comparing interreader PR measurements did not achieve statistical significance (P=0.22).
Study Measurements and Clinical Assessments
The year 1 visit comprised the baseline examination for the present analysis. Subsequent examinations included interim health history updates, hospitalizations, and current medications. Race (black or white), smoking (current/former or never), and alcohol use were determined by self-report. Moderate-to-heavy alcohol consumption was determined by self-report of ≥14 drinks for men and ≥7 drinks weekly for women. Systolic and diastolic blood pressure consisted of 2 measurements averaged with participants in a seated position. Body mass index was derived using weight divided by height squared (kg/m 2 ). Diabetes mellitus was determined from self-reported history, use of oral hypoglycemics or insulins, or fasting glucose ≥126 mg/dL. Blood samples were obtained after an 8-hour fast. Serum total and high-density lipoprotein cholesterol measures were assayed according to standardized methods (Ortho-Clinical Diagnostics, Rochester, NY). Medications taken within 2 weeks were brought to each examination and classified according to the Iowa Drug Information System, thereby identifying antihypertensive, oral hypoglycemic, or insulin medications and medications with atrioventricular nodal blocking properties (amiodarone, oral β-blockers, cardiac glycosides, and calcium channel blockers). Prevalent heart failure was determined by self-reported history or use of vasodilator, cardiac glycoside, or diuretic therapies. Prevalent coronary heart disease was determined by self-reported history of coronary artery bypass graft surgery, coronary angioplasty, history of myocardial infarction, angina, or ECG evidence of myocardial infarction by identification of an ECG major Q-wave abnormality. ECG left ventricular hypertrophy was categorized using an automated measurement of the R-wave amplitude >26 mm in precordial lead V5 or V6; R-wave amplitude >20 mm in limb lead I, II, III, or aVF; or R-wave amplitude >12 mm in limb lead aVL.
Study Events and Outcomes
Outcomes occurred during 10-year follow-up after the baseline examination and consisted of heart failure, AF, and all-cause mortality. Medical history for interim events and incident disease were reviewed at annual examinations and 6-month telephone contacts. Incident heart failure was determined by a physician diagnosis of congestive heart failure and medical treatment for heart failure (ie, combination of a diuretic and cardiac glycoside or vasodilator) requiring overnight hospitalization. Further criteria included presence of cardiomegaly or pulmonary edema by chest radiograph or evidence of ventricular dilation by cardiac imaging when available. Records from hospitalizations were obtained and reviewed. Incident heart failure cases underwent adjudication by physicians at the local research site as described previously. 12 8 Date of death was ascertained from participant proxy or other participant representative, hospital records, obituary, or search of the National Death Index. The Health ABC central Diagnosis and Disease Ascertainment Committee integrates data to review all identified deaths. Follow-up duration was determined from the baseline visit until the first event or the day of death or 10 years. Outcomes were considered independently, and participants were censored from the analysis at the date of the event or last known study contact.
Statistical Analyses
Continuous variables were examined for their mean and SDs and categorical variables for their distributions. We examined the graphical and numerical distribution of the PR interval and determined that it did not depart from normality. The relationships of covariates to the PR interval were estimated using general linear models. Models were initially adjusted for demographic variables (age, sex, race, and site). A multivariable model was then adjusted for the demographic variables and the following clinical variables: smoking history, body mass index, systolic and diastolic blood pressure, heart rate, medications (amiodarone, cardiac glycosides, calcium channel blocker, and oral β-blocker), ratio of total to high-density lipoprotein cholesterol, ECG left ventricular hypertrophy, hypertension treatment, prevalent heart failure (for AF and mortality analyses), coronary heart disease, and diabetes mellitus. The 10-year incident rates for the outcomes of heart failure, AF, and mortality were determined. Multivariable Cox proportional hazards regression models for each outcome examined PR interval per SD increase and dichotomized as ≤ or >200 ms.
We assessed for effect modification between PR interval and age, sex, and race in examining the association between PR and the outcomes of heart failure, AF, and mortality. We did not identify significant effect modification in the initial (age-, sex-, race-and siteadjusted) or the complete multivariable-adjusted Cox proportional hazards regression models. Survival curves based on stratified Cox regression models were constructed to examine differences between categorical PR and the associations with the outcomes of heart failure, AF, and mortality. We verified that the proportionality of hazards assumption was not violated.
Secondary analyses were conducted adjusting for interim heart failure before AF and for interim AF before heart failure and using medications as time-varying covariates during follow-up. The relationships of PR interval to the outcomes of AF and heart failure were examined further by constructing restricted cubic splines using the cohort mean PR as the reference and incorporating knots at 5, 27.5, 50, 72.5, and 95 quantiles as recommended by Harrell. 13 All statistical analyses used SAS version 9.2 (SAS Institute, Cary, NC). A 2-sided P<0.05 was considered statistically significant.
Results
After exclusions, 2722 Health ABC participants comprised the present analysis. The cohort's median PR interval was 168 (interquartile range, 152-188) ms and mean age was 74±3 years at baseline; 52.4% were women and 41.0% were black (Table 1) . Race was not significantly correlated with PR interval in age-, sex-and site-adjusted analyses (P=0.28). The main significant clinical correlates of PR interval were age, sex, heart rate, body mass index, and hypertension treatment.
During the course of the 10-year follow-up, 369 participants were diagnosed with heart failure, 537 with incident AF, and 832 died. Table 2 presents the incidence rate per 1000 person-years for the outcomes. There was no significant interaction between race and PR interval with the outcome of heart failure (P=0.26), AF (P=0.89), or all-cause mortality (P=0.66). Incidence rates by race are given in the online-only Data Supplement Table SI .
In multivariable-adjusted analyses ( Distributions are means (SD) or n (%) for anthropometric, clinical, and laboratory variables. Age-, sex-, site-, and race-adjusted models: each of age, sex, site, and race was adjusted for the other 3 variables. Comprehensive multivariable adjustment included adjustment for age, sex, site, race, and the remainder of the variables listed here. Selected medications are amiodarone, cardiac glycosides, calcium channel blockers, and β-blockers. Continuous variables are expressed per SD and categorical variables for the presence of variable. Estimates show the change in PR interval per SD change for continuous variables or for the presence of that variable for categorical variables. PR is expressed as median and interquartile range. BP indicates blood pressure; CI, confidence interval; HDL, high-density lipoprotein; and OR, odds ratio.
The 339 Health ABC participants in our sample with PR >200 ms had 46% increased risk of incident heart failure (95% CI, 1.11-1.93; Table 3 ). In multivariable models, PR >200 ms was not significantly associated with 10-year risk of AF (HR, 1.26; 95% CI, 0.99-1.61) and was not associated with increased all-cause risk of death (HR, 1.16; 95% CI, 0.96-1.39). We present survival curves for the outcomes of heart failure, AF, and all-cause mortality adjusted for age, sex, race, and site in the Figure using PR stratified as ≤200 ms versus >200 ms.
We developed restricted cubic splines adjusting for sex, age, race, site, and clinical correlates and used the mean PR interval, 170 ms, as the reference value because of its proximity to the median value in our cohort. Online-only Data Supplement Figure SI shows the splines for heart failure, and online-only Data Supplement Figure SII shows the splines for AF. The restricted cubic splines use the median PR value as the referent to determine HRs. The splines (HR shown in red solid line and dashed line indicating the 95% CI) demonstrate a progressive increase in HRs, with the rise in PR interval beyond the reference value of 170 ms (Wald χ 2 overall association, 5.81; P=0.01 for heart failure and 5.81; P=0.005 for AF). We further note the limited rise in the HR for both heart failure and AF identified when considering PR values less than the referent. The wide CIs, however, indicate that the association is not significant. We report the HR estimates derived from the splines for heart failure and AF using a PR of 170 ms as the referent value in the online-only Data Supplement Table SIII .
Secondary analyses examined PR as a continuous measure using multivariable models and adjusting for interim events. After adjusting for interim AF, an incremental 1-SD increase in PR interval remained associated with a 13% increased risk of heart failure during 10-year follow-up (95% CI, 1.02-1.25; P=0.006). Similarly, a 1-SD increase in PR interval remained associated with AF after adjustment for interim heart failure (HR, 1.13; 95% CI, 1.04-1.23; P=0.02).
Discussion
We examined the associations of the ECG PR interval with the 10-year risks of incident heart failure, AF, and mortality in a biracial cohort of older adults. We identified a significant association between baseline PR interval and incident heart failure and AF. Mainly, the analysis identified a 46% increased heart failure risk during the 10-year follow-up.
Our findings extend prior investigations of PR interval beyond younger or more racially homogenous cohorts. In the Framingham Heart Study, investigators identified an association between PR interval and AF highly consistent with our findings. 5, 14 In the Atherosclerosis Risk in Communities (ARIC) Study, Soliman et al 4 found a 41% increase in AF risk with each SD increase in PR interval. However, only 10 black ARIC Study participants developed AF during the ≈7-year mean follow-up period, suggesting a lower risk of AF in blacks. The mean age of the ARIC participants (54 years) was younger, limiting comparison of the findings presented here. Our results validated these prior studies concerning the importance of PR prolongation as a marker of cardiovascular risk and extended their findings by identifying that PR was associated with heart failure and AF in a markedly older, biracial cohort.
We showed that baseline PR interval in this older cohort had no association with 10-year risk of all-cause mortality in contrast to prior studies. Our study participants were older, and hence likely had a higher burden of comorbidities with greater impact on prognosis than PR.
Several mechanisms may contribute toward the association of PR interval prolongation and incident heart failure. PR interval shares clinical correlates with established heart failure risk factors. Prolongation of the PR has been associated with obesity, increased waist circumference, and components of the metabolic syndrome, 15 exposures that are associated The events column indicates the number of participants with the designated outcome out of the total eligible participants. Heart failure (white, n=201; black, n=168); atrial fibrillation (white, n=359; black, n=178); and mortality (white, n=435; black, n=397). CI indicates confidence interval. with incident heart failure. [16] [17] [18] [19] Metabolic syndrome has been previously associated with heart failure in Health ABC. 20 Hypertension is similarly a main cause for heart failure with preserved and compromised systolic function [21] [22] [23] and may promote elevated intracardiac pressures that alter atrial electric function.
PR interval progression is a marker of atrial electric and structural remodeling. Invasive electrophysiological studies have demonstrated severely altered atrial electric properties in the setting of left ventricular systolic dysfunction. 24 Electrophysiological studies have quantified increased atrial refractoriness and conduction times accompanying aging. 25, 26 PR interval prolongation may consequently be consistent with generalized atrial aging or subclinical disease. Unaccounted for residual confounding may contribute toward the findings described here as well. Further study is needed to examine how modulation of risk factors may impact atrial and atrioventricular nodal conduction.
Potential mechanisms for the pathophysiological association between PR prolongation and AF mirror those proposed for heart failure. PR interval has been associated with AF in multiple longitudinal cohort studies, as has its constituent component, P wave duration. 14, 27, 28 There has been discussion regarding the decreased prevalence of AF in blacks, despite both clinical risk factors and prolonged measures of atrial electric function, compared with whites. 9, 29 In this study of older white and black adults, we found no interaction by race between PR and the outcomes of heart failure and AF. Our findings suggest that racial differences in atrial electric function may be less relevant in older adults. PR interval reflects intra-and interatrial conduction (the P wave) through the atrioventricular node, and age-related changes in atrial conduction may not be related to race. Further studies are essential to evaluate racial differences in atrial electric function and their clinical relevance in relation to AF.
Our analysis has multiple strengths. The standardized protocol and examinations of Health ABC provide for comprehensive assessment of the covariates used here. Second, our cohort has a unique composition of community-dwelling whites and black older adults with preserved high-level baseline functional status. Our findings are relevant to the increasing number of independent older adults who are aging successfully with limited impairment. Third, electrocardiographic analyses were conducted by standardized reading and coding, thereby enhancing reliability and limiting misclassification. Fourth, heart failure and mortality are adjudicated outcomes in Health ABC.
Our study has multiple limitations. Health ABC enrolled highly functional, older adults of white and black race in the Memphis, TN, and Pittsburgh, PA, regions. Generalization to other races, ethnicities, and regions is uncertain, and generalization to less healthy older adults may also be limited. Second, the study was not designed to examine AF risk factors in older adults. Hence, AF was not an adjudicated outcome in Health ABC. The reliance on Center for Medicare and Medicaid coding for AF determination is another limitation because it may result in misclassification of AF. Third, heart failure events were determined by review of hospitalizations. Survival curves showing the electrocardiographic PR interval stratified at ≤200 ms and >200 ms and incident outcomes examined during 10-year follow-up. A, Variation in heart failure incidence according to PR categories. B, Variation in atrial fibrillation incidence according to PR categories. C, Absence of variation in all-cause mortality between the PR strata. All survival curves were adjusted for age, sex, race, and site.
As recognized in an analysis of heart failure in Health ABC, this may underestimate heart failure cases and bias toward identification of more severe heart failure. 12 We were not able to distinguish between heart failure with preserved or compromised ejection fractions, which may vary in their association with PR interval. Furthermore, Health ABC did not include baseline echocardiography. Inclusion of additional data not available here, such as echocardiographic diastolic indices, systolic function, chamber sizes, and left ventricular mass, may potentially eliminate the predictive value of the PR interval. Another limitation consisted in using a single determination of PR interval at the initial Health ABC examination. Residual confounding from PR interval variability is not accounted for in our analysis. However, we would expect the misclassification of PR interval to be nondifferential and bias our results toward the null. Finally, we cannot exclude residual confounding from other clinical variables that were not included in our multivariable adjustment.
In conclusion, we examined the association of PR interval with adverse outcomes. We found an association between PR interval and heart failure risk. We extended prior analyses of the relationship of PR interval to AF by examining AF risk in an older, biracial cohort. Contrary to our expectations based on prior literature, we found no interaction between race and PR interval in examining the association of PR interval with the outcomes we studied. The ECG is widely used in clinical practice, is of low cost, and includes automated determination of PR interval. Our analyses adjusted for anthropometric and clinical risk factors relevant to cardiovascular disease and related to incident heart failure and AF. 12, 30, 31 Inclusion of such diverse covariates is meaningful: clinicians evaluate PR interval in the context of widely established risk factors and clinical history without considering PR interval in isolation. As the general population continues to age, further strategies for heart failure and AF risk stratification are essential for evaluating and treating those at increased risk. Our investigation suggests that PR interval may contribute toward identifying older adults at increased risk for the adverse outcomes examined here. Further investigation is necessary to incorporate PR interval into risk classification schemes for prevention strategies and to determine whether such treatment strategies will reduce risks of heart failure or AF.
